引用次数
引用: 4,507
H-指数: 36
I10-指数 : 59
出版物: 182
Multiple cases of squamous cell carcinoma of the tongue and oral cavity in patients treated with long-term pegylated liposomal doxorubicin (PLD) for ovarian cancer.
T. L. Cannon , F. Muggia , D. Hirsch , E. A. Andreopoulou
Journal of Clinical Oncology 29 5557 -5557
6
2011
Cetuximab in mucinous peritoneal carcinomatosis: Assessment by serial CA19.9 and CEA measurements
Howard Hochster , Andrew Lowy , Juliet Escalon , Malek Safa
Cancer Research 67 3531 -3531
2007
Comparison of circulating tumor cells (CTCs) in metastatic breast cancer (MBC): AdnaTest breast cancer for detection and biological characterization
Massimo Cristofanilli , James Reuben , Diana Urbauer , Vicente Valero
Clinical Cancer Research 14
4
2008
A pilot study of letrozole for one year in women at enhanced risk of developing breast cancer: effects on mammographic density.
Minerva Utate , Hildegard Toth , Deborah Axelrod , Elsa Reich
Anticancer Research 32 ( 4) 1327 -1331
14
2012
Weekly paclitaxel with intermittent imatinib mesylate (Gleevec): tolerance and activity in recurrent epithelial ovarian cancer.
Amy Tiersten , Bhavana Pothuri , Lucia Borgato , Stephanie Blank
Anticancer Research 30 ( 9) 3243 -3247
17
2010
Seeing red: anthracyclines for breast cancer.
Joseph A. Sparano , Eleni Andreopoulou
Oncology 25 ( 2)
2011
Circulating Tumor Cells: Toward Sophisticated Approaches in Managing Metastatic Breast Cancer
Massimo Cristofanilli , Eleni Andreopoulou
Oncology 22 ( 7)
2008
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study.
Vassiliki Karantza , Sara M. Tolaney , Virginia G. Kaklamani , Debra A. Patt
Clinical Cancer Research 27 ( 11) 3061 -3068
2021
Preliminary report of a phase 1b/2a trial, an oral inhibitor of phosphorylated P68 (P-p68) which mediates β-catenin nuclear translocation in advanced triple-negative breast cancer (TNBC).
Jennifer Robinson Diamond , Pavani Chalasani , Eleni Andreopoulou , William Larry Gluck
Journal of Clinical Oncology 36 1097 -1097
1
2018
Abstract C39: Phase I clinical trial of CX‐4945: A first‐in‐class orally administered small molecule inhibitor of protein kinase CK2
Robert F. Marschke , Eleni Andreopoulou , Daniel D. Von Hoff , John K.C. Lim
Molecular Cancer Therapeutics 8
2
2009
Circulating tumor cells as prognostic marker in metastatic breast cancer
Eleni Andreopoulou , Massimo Cristofanilli
Expert Review of Anticancer Therapy 10 ( 2) 171 -177
28
2010
Abstract P1-19-32: Phase I/II trial of ruxolitinib in combination with trastuzumab in HER2+ metastatic breast cancer (MBC)
Kevin Kalinsky , Shing Lee , Amy Tiersten , Della F Makower
Cancer Research 80
2020
Molecular dissection of cancers - another piece in the puzzle to better assess, and treat, disease using biomarkers that correlate with disease type and stage.
Felix Frueh , Amalia Issa , Eleni Andreopoulou , Massimo Cristofanilli
Personalized Medicine 5 ( 3) 211 -213
2008
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer
Verena Sailer , Kenneth Wa Eng , Tuo Zhang , Rohan Bareja
JCO precision oncology 3 ( 3) 1 -12
13
2019
Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531.
CheukMan C Au , John B Furness , Kara Britt , Sofya Oshchepkova
eLife 9
2
2020
Ethnic differences in tumor proliferation in women with early-stage breast cancer.
Kevin Kalinsky , Emerson A. Lim , Eleni Andreopoulou , Avni Mukund Desai
Journal of Clinical Oncology 31 560 -560
2013
A phase I-II study of tipifarnib plus weekly paclitaxel (P) followed by dose-dense doxorubicin/cyclophosphamide (AC) in stage IIb-IIIc breast cancer (BC).
Eleni Andreopoulou , Ivette Sara Vigoda , Vicente Valero , Dawn L. Hershman
Journal of Clinical Oncology 31 ( 15_suppl) 1118 -1118
2013
Protein pathway activation mapping guided biomarker development to identify optimal combinations of MEK inhibitor with PI3K/mTOR pathway inhibitors for the treatment of triple-negative breast cancer.
Sarah J. Schweber , Alicia G. Rodriguez-LaRocca , Valerie Calvert , Emanuel Petricoin
Journal of Clinical Oncology 31 2612 -2612
1
2013
Documentation of Complete Response in Metastatic Breast Cancer to Liver and Bone Achieved with Trastuzumab and Pegylated Liposomal Doxorubicin
Boris Kobrinsky , Eleni Andreopoulou , Karen Mourtzikos , Franco Muggia
Clinical Medicine: Oncology 2 ( 2) 469 -470
3
2008
Squamous Cell Carcinoma of the Oral Cavity in Nonsmoking Women: A New and Unusual Complication of Chemotherapy for Recurrent Ovarian Cancer?
Timothy L Cannon , Dominic W Lai , David Hirsch , Mark Delacure
Oncologist 17 ( 12) 1541 -1546
32
2012